COM:PANBELA
Panbela Therapeutics
- Stock
Last Close
0.35
22/11 20:00
Market Cap
1.71M
Beta: -
Volume Today
5.21K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||||
average payables | 16.07K - | 2.17K 86.51% | 292.67K 13,402.65% | 915K 212.64% | 1.22M 33.39% | 1.13M 7.41% | 830.50K 26.50% | 575.50K 30.70% | 597K 3.74% | 1.75M 193.55% | 6.40M 265.31% | |
average receivables | 299.59K - | 300.31K 0.24% | 479.96K 59.82% | 527K 9.80% | 370.50K 29.70% | 376K 1.48% | 346.50K 7.85% | 342K 1.30% | 322K 5.85% | 185K 42.55% | 24.50K 86.76% | |
book value per share | -1.15K - | -1.76K 52.99% | -2.29K 30.12% | -1.79K 21.62% | -1.24K 30.75% | 68.98 105.56% | 291.58 322.68% | 1.31K 349.62% | 1.05K 20.13% | -15.65 101.49% | -43.33K 276,823.74% | |
capex per share | -42.63 - | -1.28 - | ||||||||||
capex to depreciation | -0.58 - | |||||||||||
capex to operating cash flow | 0.14 - | 0.04 - | ||||||||||
capex to revenue | -0.01 - | 0.40 - | ||||||||||
cash per share | 490.18 - | 1.36K 178.42% | 789.25 42.17% | 169.18 78.56% | 51.16 69.76% | 361.65 606.88% | 515.58 42.56% | 1.40K 171.55% | 1.22K 13.09% | 2.50 99.79% | 23.72K 949,325.71% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 2.61 - | 0.21 92.01% | 39.22 18,709.91% | 87.93 124.19% | 72.56 17.48% | 99.81 37.55% | 50.42 49.49% | 35.14 30.30% | 23.34 33.59% | 30.67 31.44% | 141.45 361.15% | |
days sales outstanding | 140.07 - | 61.04 56.42% | -10.92 - | |||||||||
debt to assets | 1.09 - | 1.42 29.63% | 1.84 29.81% | 3.74 103.18% | 2.38 36.32% | 0.18 92.25% | 0.04 79.99% | 1.37 - | 0.08 93.84% | |||
debt to equity | -4.22 - | -2.73 35.19% | -1.24 54.64% | -0.71 43.08% | -0.49 29.92% | 1.31 363.98% | 0.08 93.59% | -0.85 - | -0.21 75.03% | |||
dividend yield | ||||||||||||
earnings yield | -8.03 - | -3.72 53.72% | -1.50 59.61% | -2.84 88.95% | -0.29 89.74% | -0.36 24.37% | -0.26 28.44% | -0.17 33.12% | -0.50 189.01% | -0.78 54.88% | -12.70K 1,638,161.62% | |
enterprise value | 549.27K - | 441.80K 19.57% | 5.68M 1,186.03% | 4.64M 18.32% | 37.33M 704.25% | 15.26M 59.11% | 21.61M 41.57% | 18.51M 14.35% | 8.38M 54.72% | 50.62M 504.01% | -1.58M 103.11% | |
enterprise value over ebitda | -3.29 - | -7.15 117.44% | -1.05 85.38% | -0.90 14.05% | -6.21 590.74% | -3.51 43.39% | -4.89 39.14% | -3.59 26.46% | -0.79 78.03% | -1.46 84.40% | 0.03 102.11% | |
ev to operating cash flow | -15.52 - | -38.57 148.54% | -1.46 96.22% | -1.94 32.74% | -10.97 466.90% | -6.39 41.72% | -7.89 23.38% | -4.80 39.13% | -1.25 73.97% | -3.31 165.08% | 0.06 101.88% | |
ev to sales | 0.56 - | 0.33 42.28% | -30.90 - | |||||||||
free cash flow per share | -337.54 - | -95.44 71.72% | -3.33K 3,383.89% | -926.23 72.14% | -1.15K 23.63% | -614.41 46.34% | -576.63 6.15% | -598.08 3.72% | -687.38 14.93% | -30.98 95.49% | -232.30K 749,701.08% | |
free cash flow yield | -1.53 - | -0.40 74.08% | -1.19 198.62% | -1.33 12.06% | -0.10 92.83% | -0.15 53.31% | -0.11 21.79% | -0.14 22.36% | -0.33 136.51% | -0.35 6.81% | -12.69K 3,589,111.74% | |
graham net net | -2.76K - | -2.37K 14.18% | -2.57K 8.63% | -1.87K 27.31% | -1.34K 28.18% | 6.18 100.46% | 202.26 3,174.13% | 1.23K 506.06% | 968.70 20.98% | -22.76 102.35% | -128.20K 563,247.43% | |
graham number | 6.76K - | 5.94K 12.11% | 14.71K 147.64% | 8.92K 39.33% | 9.88K 10.66% | 1.54K 84.45% | 2.93K 90.52% | 4.67K 59.65% | 4.95K 5.91% | 154.63 96.87% | 476.05K 307,754.29% | |
income quality | 0.17 - | 0.11 35.90% | 0.79 639.25% | 0.47 40.69% | 0.33 30.09% | 0.40 23.27% | 0.44 9.29% | 0.81 82.97% | 0.66 18.17% | 0.44 33.89% | 1.00 128.55% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -5.41 - | -2.12 60.80% | -29.75 1,301.73% | -28.71 3.49% | -3.72 87.04% | -2.14 42.35% | -1.97 8.16% | -338.47 17,081.96% | -910 168.86% | -118.38 86.99% | 161.81 236.69% | |
interest debt per share | 5.15K - | 5.10K 0.86% | 2.99K 41.34% | 1.34K 55.39% | 1.16K 13.24% | 557.01 51.92% | 486.32 12.69% | 2.64 99.46% | 1.13 57.25% | 13.87 1,129.37% | 6.28K 45,220.07% | |
inventory turnover | ||||||||||||
invested capital | -4.22 - | -2.73 35.19% | -1.24 54.64% | -0.71 43.08% | -0.49 29.92% | 1.31 363.98% | 0.08 93.59% | -0.85 - | -0.21 75.03% | |||
market cap | 26.40K - | 28.80K 9.09% | 3.28M 11,294.44% | 1.80M 45.09% | 35.65M 1,878.53% | 16.32M 54.23% | 23.94M 46.72% | 27.53M 14.99% | 20.25M 26.45% | 45.06M 122.54% | 1.99K 100.00% | |
net current asset value | -237.31K - | -227.00K 4.35% | -2.76M 1,114.55% | -4.64M 68.37% | -3.69M 20.53% | 217K 105.88% | 1.33M 514.75% | 8.39M 529.09% | 9.62M 14.62% | -11.25M 216.96% | -13.45M 19.57% | |
net debt to ebitda | -3.13 - | -6.68 113.53% | -0.44 93.39% | -0.55 24.47% | -0.28 49.39% | 0.24 187.30% | 0.53 117.34% | 1.75 232.04% | 1.12 36.18% | -0.16 114.30% | 0.03 119.24% | |
net income per share | -1.77K - | -892.03 49.51% | -4.20K 371.27% | -1.97K 53.03% | -3.49K 76.84% | -1.52K 56.47% | -1.31K 14.12% | -739.91 43.31% | -1.04K 40.44% | -67.91 93.46% | -232.43K 342,139.58% | |
operating cash flow per share | -294.92 - | -95.44 67.64% | -3.33K 3,383.89% | -926.23 72.14% | -1.15K 23.63% | -614.41 46.34% | -576.63 6.15% | -598.08 3.72% | -687.38 14.93% | -29.70 95.68% | -232.30K 782,096.26% | |
payables turnover | 139.79 - | 1.75K 1,152.19% | 9.31 99.47% | 4.15 55.39% | 5.03 21.18% | 3.66 27.30% | 7.24 97.97% | 10.39 43.47% | 15.64 50.59% | 11.90 23.92% | 2.58 78.32% | |
receivables turnover | 2.61 - | 5.98 129.48% | -33.43 - | |||||||||
research and ddevelopement to revenue | 0.29 - | -17.12 - | ||||||||||
return on tangible assets | -0.40 - | -0.26 33.99% | -2.73 936.43% | -5.83 113.90% | -13.53 132.04% | -3.11 77.00% | -1.97 36.62% | -0.49 75.36% | -0.79 62.05% | -7.02 791.26% | -2.14 69.50% | |
revenue per share | 8.12K - | 11.31K 39.35% | -3.18 - | |||||||||
roe | 1.54 - | 0.51 67.00% | 1.84 262.18% | 1.10 40.08% | 2.81 155.36% | -22.03 883.52% | -4.48 79.68% | -0.56 87.39% | -0.99 75.85% | 4.34 537.30% | 5.36 23.59% | |
roic | -0.42 - | -0.20 52.62% | -7.33 3,541.97% | 3.55 148.43% | 3.07 13.54% | -6.04 296.70% | -2.70 55.29% | -0.64 76.23% | -0.94 45.80% | 28.20 3,115.36% | 13.72 51.33% | |
sales general and administrative to revenue | 0.34 - | 0.62 82.13% | -3.69 - | |||||||||
shareholders equity per share | -1.15K - | -1.76K 52.99% | -2.29K 30.12% | -1.79K 21.62% | -1.24K 30.75% | 68.98 105.56% | 291.58 322.68% | 1.31K 349.62% | 1.05K 20.13% | -15.65 101.49% | -43.33K 276,823.74% | |
stock based compensation to revenue | 0.00 - | -0.66 - | ||||||||||
tangible asset value | -137.89K - | -210.96K 52.99% | -2.68M 1,170.86% | -4.64M 73.14% | -3.69M 20.53% | 268K 107.26% | 1.39M 416.79% | 8.45M 509.96% | 10.21M 20.88% | -8.05M 178.82% | -4.71M 41.48% | |
tangible book value per share | -1.15K - | -1.76K 52.99% | -2.29K 30.12% | -1.79K 21.62% | -1.24K 30.75% | 68.98 105.56% | 291.58 322.68% | 1.31K 349.62% | 1.05K 20.13% | -15.65 101.49% | -43.33K 276,823.74% | |
working capital | -230.85K - | -224.59K 2.71% | 357K 258.96% | -4.64M 1,400.28% | -3.40M 26.69% | 217K 106.38% | 1.33M 514.75% | 8.39M 529.09% | 9.62M 14.62% | -6.06M 162.96% | -9.26M 52.87% |
All numbers in (except ratios and percentages)